XML 33 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Supplemental Quarterly Information (Unaudited)
12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Supplemental Quarterly Information (Unaudited) SUPPLEMENTAL QUARTERLY INFORMATION (UNAUDITED)
The following table represents the significant items for the results of operations on a quarterly basis for the years ended December 31, 2019 and 2018:
 
Three Months
Ended
March 31,
2019
 
Three Months
Ended
June 30,
2019
 
Three Months
Ended
September 30,
2019
 
Three Months
Ended
December 31,
2019
Revenues from continuing operations
$
478,209

 
$
560,643

 
$
584,372

 
$
1,018,169

Gross profit (loss) from continuing operations
(12,792
)
 
(26,772
)
 
24,076

 
545,557

Selling, general, and administrative expenses including research and development expense
25,354

 
27,041

 
24,762

 
41,052

Impairment of property, plant and equipment

 
468

 
11,145

 
595

Income (loss) from operations
(38,146
)
 
(54,281
)
 
(11,831
)
 
503,910

Other expense, net
(3,671
)
 
(3,444
)
 
(2,551
)
 
(825
)
Net income (loss) from continuing operations
(41,387
)
 
(57,635
)
 
(13,753
)
 
502,506

Net income (loss) from discontinued operations
(2,017
)
 
(4,462
)
 
(2,193
)
 
(995
)
Net income
$
(43,404
)
 
$
(62,097
)
 
$
(15,946
)
 
$
501,511

Net income (loss) from continuing operations available to common stockholders
$
(41,387
)
 
$
(57,635
)
 
$
(13,753
)
 
$
492,556

Net income (loss) from discontinued operations available to common stockholders
$
(2,017
)
 
$
(4,462
)
 
$
(2,193
)
 
$
(995
)
Basic net income (loss) per share available to common stockholders:
 
 
 
 
 
 
 
Continuing operations
$
(1.11
)
 
$
(1.52
)
 
$
(0.35
)
 
$
12.64

Discontinued operations
$
(0.05
)
 
$
(0.12
)
 
$
(0.06
)
 
$
(0.03
)
Net income (loss) per share
$
(1.16
)
 
$
(1.64
)
 
$
(0.41
)
 
$
12.62

Diluted net income (loss) per share available to common stockholders:
 
 
 
 
 
 
 
Continuing operations
$
(1.11
)
 
$
(1.52
)
 
$
(0.35
)
 
$
11.52

Discontinued operations
$
(0.05
)
 
$
(0.12
)
 
$
(0.06
)
 
$
(0.03
)
Net income (loss)
$
(1.16
)
 
$
(1.64
)
 
$
(0.41
)
 
$
11.50

 
Three Months
Ended
March 31,
2018
 
Three Months
Ended
June 30,
2018
 
Three Months
Ended
September 30,
2018
 
Three Months
Ended
December 31,
2018
Revenues from continuing operations
$
688,002

 
$
578,900

 
$
596,324

 
$
519,761

Gross profit loss from continuing operations
249,455

 
57,514

 
51,159

 
61,863

Selling, general, and administrative expenses including research and development expense
32,688

 
24,539

 
21,933

 
27,579

Impairment of property, plant and equipment

 

 

 
879

Income from operations
216,767

 
32,975

 
29,226

 
33,405

Other income (expense), net
(128
)
 
(96
)
 
(2,900
)
 
250

Net income from continuing operations
217,844

 
29,042

 
25,472

 
31,270

Net income (loss) from discontinued operations
(3,455
)
 
4,808

 
(469
)
 
(12,196
)
Net income
$
214,389

 
$
33,850

 
$
25,003

 
$
19,074

Net income from continuing operations available to common stockholders
$
212,608

 
$
28,277

 
$
24,799

 
$
30,448

Net income (loss) from discontinued operations available to common stockholders
$
(3,455
)
 
$
4,681

 
$
(469
)
 
$
(12,197
)
Basic net income (loss) per share available to common stockholders:
 
 
 
 
 
 
 
Continuing operations
$
5.48

 
$
0.76

 
$
0.67

 
$
0.82

Discontinued operations
$
(0.09
)
 
$
0.13

 
$
(0.01
)
 
$
(0.33
)
Net income per share
$
5.39

 
$
0.88

 
$
0.65

 
$
0.50

Diluted net income (loss) per share available to common stockholders:
 
 
 
 
 
 
 
Continuing operations
$
5.38

 
$
0.67

 
$
0.55

 
$
0.66

Discontinued operations
$
(0.09
)
 
$
0.11

 
$
(0.01
)
 
$
(0.33
)
Net income per share
$
5.30

 
$
0.78

 
$
0.53

 
$
0.40


The results for the three months ended September 30, 2019 reflect an impairment related to the Company's New Boston facility's property, plant and equipment assets resulting from the closing of the plant. Refer to Note 2 for further details. The results for the three months ended December 31, 2019 reflect the full recognition in revenue the effect of the retroactive reinstatement of the 2018 and 2019 BTC. The net benefit of the BTC was $260,850 and $238,564 related to the business conducted in 2019 and 2018, respectively. The results for the three months ended March 31, 2018 reflected the full recognition of the effect of the 2017 BTC retroactive reinstatement of $206,521.